Charles Gellman

Charles Gellman is a reviewer for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH). His role involves evaluating proposals from small businesses seeking funding for research and development projects that aim to address various health-related challenges.

Gellman has highlighted the significance of these programs in fostering innovation and supporting small businesses in the healthcare sector. He emphasizes that the SBIR and STTR initiatives provide critical funding opportunities that enable companies to develop innovative products and technologies, particularly in areas with unmet medical needs.1

In addition to his work at NIH, Gellman is active on LinkedIn, where he shares insights related to his professional experiences and updates about grants awarded to small businesses, such as a recent Phase II SBIR grant awarded to HiDO Technologies for dementia care technology.2 His contributions reflect a commitment to enhancing research capabilities within the small business community, ultimately aiming to improve health outcomes through innovative solutions.